US Patent Issued to VISOLIS on Feb. 18 for "Highly sustainable compositions for modulation of gene expression in human skin, and methods of production thereof" (California Inventor)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,379, issued on Feb. 18, was assigned to VISOLIS INC. (Dover, Del.).

"Highly sustainable compositions for modulation of gene expression in human skin, and methods of production thereof" was invented by Deepak Dugar (Berkeley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Formulations containing biologically-produced, high-purity R-mevalonolactone are provided for modulating the expression of genes and metabolism related to epidermal turnover, hyaluronic acid synthesis, barrier function, anti-aging elasticity, extracellular matrix degradation, inflammation, stress, and pigmentation in human skin. The biologically-produced, high-purity R-mevalo...